Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer

[1]  R. Livingston,et al.  [A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer]. , 2001, Cancer Radiothérapie.

[2]  Renato Martins,et al.  Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.

[3]  R. Rosell,et al.  ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association , 2005 .

[4]  H. Kato,et al.  A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). , 2004, Lung cancer.

[5]  H. Wada,et al.  Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan). , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  R. Arriagada,et al.  Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients , 1995 .

[8]  Robert N. Hughes,et al.  Cancer: Principles and Practice of Oncology , 2005 .

[9]  L. Seymour,et al.  O-58 Quality of life in a trial of adjuvant chemotherapy for early stage completely resected non-small cell lung cancer (NCIC CTG BR.10) , 2003 .

[10]  G. Giaccone,et al.  Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. , 2003, Journal of the National Cancer Institute.

[11]  R. Gralla,et al.  Does adjuvant chemotherapy improve survival in non small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit , 2005 .

[12]  The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  G. Luporini,et al.  Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. , 1999, Journal of the National Cancer Institute.

[14]  H. Wada,et al.  Postoperative oral administration of UFT for completely resected pathologic stage I non-small cell lung cancer: the West Japan study group for lung cancer surgery (WJSG), the 4th study , 2001 .

[15]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[16]  S. Burdett,et al.  Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.

[17]  R. Gray,et al.  Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial - E4599 , 2005 .

[18]  R. Schilsky,et al.  Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. Wada,et al.  Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  C. Gridelli,et al.  Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence. , 2005, Chest.

[21]  H. Wada,et al.  Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Mustafa.  Abstract , 1952 .

[23]  M. Gail,et al.  Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Bengt Bergman,et al.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.

[25]  C. Bokemeyer,et al.  Adjuvant chemotherapy after complete resection of non-small cell lung cancer. , 2008, Deutsches Arzteblatt international.

[26]  M. Handa,et al.  A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. , 2003, Lung cancer.

[27]  Robert Livingston,et al.  Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.

[28]  K. Matsuo,et al.  Role of Adjuvant Chemotherapy in Patients With Resected Non-Small-Cell Lung Cancer: Reappraisal With a Meta-analysis of Randomized Controlled Trials , 2006 .

[29]  E. Holmes.  Postoperative chemotherapy for non-small-cell lung cancer. , 1993, Chest.

[30]  C. Gridelli,et al.  Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials , 2005, BMC Cancer.

[31]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[32]  F. Shepherd,et al.  Improving Survival and Reducing Toxicity with Chemotherapy in Advanced Non-Small Cell Lung Cancer , 2005, Treatments in respiratory medicine.

[33]  T. Treasure,et al.  Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. , 2004, The Journal of thoracic and cardiovascular surgery.

[34]  富永 祐民,et al.  A Randomized Controlled Trial of Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer , 1992 .

[35]  R. Gray,et al.  O-086a Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial — E4599 , 2005 .

[36]  Schell,et al.  Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know. , 1998, The oncologist.

[37]  Y. Shim,et al.  Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[38]  R. Tsuchiya,et al.  Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. , 1993, The Journal of thoracic and cardiovascular surgery.

[39]  O. Brodin,et al.  Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .

[40]  C. Gridelli,et al.  Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  M. Parmar,et al.  Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  L. Rubinstein,et al.  Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group. , 1993, Journal of the National Cancer Institute.

[43]  L. Rubinstein,et al.  Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence. , 1988, International journal of radiation oncology, biology, physics.

[44]  S. Pyrhönen,et al.  Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  O. Doi,et al.  Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer. Results of a Prospective Randomized Study. , 1992 .

[46]  H. Kato,et al.  A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.

[47]  M. Imaizumi.  Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer. , 2005, Lung cancer.

[48]  Y. Ichinose,et al.  [Adjuvant chemotherapy for non-small cell lung cancer]. , 2006, Gan to kagaku ryoho. Cancer & chemotherapy.